Bone; Scott

Patent Applications and Registrations

Patent applications and USPTO patent grants for Bone; Scott.The latest application filed is for "amorphous kinase inhibitor formulations and methods of use thereof".

Company Profile

6.5.10

Bone; Scott - Bend OR

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof App 20220265623 - Kaufman; Michael D. ; et al.	2022-08-25
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof App 20220265622 - Kaufman; Michael D. ; et al.	2022-08-25
Compositions Of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea App 20220257574 - Kaufman; Michael D. ; et al.	2022-08-18
Compositions of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea Grant 11,395,818 - Kaufman , et al. July 26, 2	2022-07-26
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof App 20220031677 - Kaufman; Michael D. ; et al.	2022-02-03
Amorphous kinase inhibitor formulations and methods of use thereof Grant 11,185,535 - Kaufman , et al. November 30, 2	2021-11-30
Compositions Of 1-(4-bromo-5-(1-ethyl-7-(methylamino)-2-oxo-1,2-dihydro-1,6-naphthyridin-- 3-yl)-2-fluorophenyl)-3-phenylurea App 20210196693 - Kaufman; Michael D. ; et al.	2021-07-01
Amorphous Kinase Inhibitor Formulations And Methods Of Use Thereof App 20210196692 - Kaufman; Michael D. ; et al.	2021-07-01
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-methylcyclohexane-1-carboxamide App 20210128564 - Bone; Scott ; et al.	2021-05-06
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H- -purin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,898,488 - Bone , et al. January 26, 2	2021-01-26
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-met App 20200237767 - Bone; Scott ; et al.	2020-07-30
Compositions and methods of use of cis-4-[2-{[3S,4R)-3-fluorooxan-4-yl]amino}8-(2,4,6-trichloroanilino)-9H-p- urin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,653,697 - Bone , et al.	2020-05-19
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-met App 20200113908 - Bone; Scott ; et al.	2020-04-16
Compositions and methods of use of cis-4-[2-{[(3S,4R)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9H- -purin-9-yl]-1-methylcyclohexane-1-carboxamide Grant 10,543,214 - Bone , et al. Ja	2020-01-28
Compositions And Methods Of Use Of Cis-4-[2-{[(3s,4r)-3-fluorooxan-4-yl]amino}-8-(2,4,6-trichloroanilino)-9h- -purin-9-yl]-1-methylcyclohexane-1-carboxamide App 20190099425 - Bone; Scott ; et al.	2019-04-04

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.